IASLC tumor budding grade identifies high-risk patients with resected lung squamous cell carcinoma
Medical Xpress 1 views
Topic timeline
Iaslc
How reporting on this topic developed over time — coverage by day, outlet counts, and multi-source storylines where they exist.
Coverage evolution
What HappeningNow has tracked so far
- Earliest shown
- Sep 12
- Latest update
- Sep 16
- Outlets
- 1
- Stories
- 4
Not enough independent coverage yet to show how reporting developed. The facts below are direct observations from the tracked window.
-
Earliest in tracked window
Oldest report in the coverage window currently tracked for this topic.
Subcutaneous tarlatamab shows favorable safety profile and antitumor activity in extensive-stage small cell lung cancer Medical Xpress · Sep 12, 2026 -
Latest update
Most recent tracked report from Medical Xpress.
IASLC tumor budding grade identifies high-risk patients with resected lung squamous cell carcinoma Medical Xpress · 1h ago
Chronological reports
4 reports in date order. Not enough independent coverage yet to show a development timeline.
